Hilka Rauert-Wunderlich

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

Cell death discovery

Cancers

Blood

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, Marlene Schwarzfischer, Viktoria Fuhr, Hilka Rauert-Wunderlich, Anne Krügl, Theodora Nedeva, Tina Grieb, Julia Pickert, Hanna Koch, Torsten Steinbrunn, Otto-Jonas Bayrhof, Ralf Christian Bargou, Andreas Rosenwald, Thorsten Stühmer, Ellen Leich
Functional Investigation of IGF1R Mutations in Multiple Myeloma. Cancers 16 (11) (2024)
Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, Marlene Schwarzfischer, Viktoria Fuhr, Hilka Rauert-Wunderlich, Anne Krügl, Theodora Nedeva, Tina Grieb, Julia Pickert, Hanna Koch, Torsten Steinbrunn, Otto-Jonas Bayrhof, Ralf Christian Bargou, Andreas Rosenwald, Thorsten Stühmer, Ellen Leich
Functional Investigation of IGF1R Mutations in Multiple Myeloma. Cancers 16 (11) (2024)
Hilka Rauert-Wunderlich
EGR1 changes course in B-cell lymphoma. Blood 142 (22) (2023)
Johannes Duell, Alexander Michael Leipold, Silke Appenzeller, Viktoria Fuhr, Hilka Rauert-Wunderlich, Matteo Claudio Da Via, Oliver Dietrich, Christophe Toussaint, Fabian Imdahl, Florian Eisele, Nazia Afrin, Lars Grundheber, Hermann Einsele, Niels Weinhold, Andreas Rosenwald, Max S Topp, Antoine-Emmanuel Saliba, Leo Rasche
Sequential Antigen-loss and Branching Evolution in Lymphoma after CD19- and CD20-Targeted T-cell Redirecting Therapy. Blood (2023)
Alberto Zamò, Elena Gerhard-Hartmann, German Ott, Ioannis Anagnostopoulos, David W Scott, Andreas Rosenwald, Hilka Rauert-Wunderlich
Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series. Virchows Archiv : an international journal of pathology (2022)
Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, Angela Riedel, Johannes Düll, Elena Gerhard-Hartmann, Andreas Rosenwald, Hilka Rauert-Wunderlich
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma. Cell death discovery 8 (1) (2022)
Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, Angela Riedel, Johannes Düll, Elena Gerhard-Hartmann, Andreas Rosenwald, Hilka Rauert-Wunderlich
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma. Cell death discovery 8 (1) (2022)
Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, Angela Riedel, Johannes Düll, Elena Gerhard-Hartmann, Andreas Rosenwald, Hilka Rauert-Wunderlich
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma. Cell death discovery 8 (1) (2022)
Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, Angela Riedel, Johannes Düll, Elena Gerhard-Hartmann, Andreas Rosenwald, Hilka Rauert-Wunderlich
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma. Cell death discovery 8 (1) (2022)
Hilka Rauert-Wunderlich, Anja Mottok, David W Scott, Lisa M Rimsza, German Ott, Wolfram Klapper, Michael Unterhalt, Hanneke C Kluin-Nelemans, Olivier Hermine, Sylvia Hartmann, Christoph Thorns, Grzegorz Rymkiewicz, Harald Holte, Martin Dreyling, Eva Hoster, Andreas Rosenwald
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network. British journal of haematology 184 (4) (2018)

Hilka Rauert-Wunderlich.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hilka Rauert-Wunderlich